I'm LongbridgeAI, I can summarize articles.Elevance Health Inc. (ELV) shares rose 1.07% to $400.54 on Friday, underperforming the broader market and some competitors despite a positive trading session. The S&P 500 and Dow Jones gained 0.43% and 0.98% respectively. Elevance closed 8.18% below its 52-week high of $436.24. In comparison, UnitedHealth Group rose 1.37%, Cigna Group increased 1.13%, while Humana Inc. fell 0.49%. Data compiled August 21, 2026.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Elevance Health Inc. (ELV) rose 1.07% to $400.54 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.43% to 7,674.37 and the Dow Jones Industrial Average rising 0.98% to 53,277.01.
Elevance Health Inc. closed 8.18% short of its 52-week high of $436.24, which the company achieved on July 14th.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as UnitedHealth Group Inc. (UNH) rose 1.37% to $390.11, Cigna Group (CI) rose 1.13% to $277.51, and Humana Inc. (HUM) fell 0.49% to $378.88.
Data source: Dow Jones Market Data, FactSet. Data compiled August 21, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
08-21-26 1642ET